Radiation dermatitis is a side effect of external beam ionizing radiation. It is also known as radiodermatitis, x-ray dermatitis, radiation skin damage or a radiation burn. Most commonly, radiation-induced dermatitis is caused by radiotherapy for underlying malignancies. It may also occur due to the exposure to radiation during interventional procedures such as coronary angiography, embolization procedures, and indwelling catheter placements. Irradiation of the skin leads to a complex pattern of direct tissue injury involving damage to cells of the epidermis and endothelial cells within the walls of blood vessels, and inflammatory cell recruitment. Many small studies have investigated the use of topical therapies, as either preventative agents or for management of skin reactions as they occur.
DelveInsight’s, “Radiodermatitis Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Radiodermatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Some of Radiodermatitis Companies are:
Request for free Sample Report: https://www.delveinsight.com/sample-request/radiodermatitis-pipeline-insight
DelveInsight’s Radiodermatitis Report covers around 3+ products under different phases of clinical development like:
Some of Radiodermatitis Therapies are:
Current Radiodermatitis Treatment Scenario and Radiodermatitis Emerging Therapies:
Table of Contents:
Introduction
Executive Summary
Radiodermatitis: Overview
Pipeline Therapeutics
Therapeutic Assessment
Radiodermatitis – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Radiodermatitis Collaboration Deals
Late Stage Products (Phase III)
Drug name: Company name
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
TEMPOL: Matrix Biomed
Pre-clinical and Discovery Stage Products
Inactive Products
Radiodermatitis Key Companies
Radiodermatitis Key Products
Radiodermatitis- Unmet Needs
Radiodermatitis- Market Drivers and Barriers
Radiodermatitis- Future Perspectives and Conclusion
Radiodermatitis Analyst Views
Appendix
Request for Detailed TOC: https://www.delveinsight.com/sample-request/radiodermatitis-pipeline-insight
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/radiodermatitis-pipeline-insight